Pfizer’s CTI, Jeffrey Modell Foundation to develop new drugs for immunological diseases
As part of the collaboration, both the parties will identify and co-fund translational research projects with leading academic medical centers within the CTI network. JMF noted that the
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.